Summary of the demographic data for 21 patients with gastroparesis (GP) receiving chronic high doses of domperidone therapy
| Demographics | n=21 (%) |
| Mean age (SD) | 50.1 (16.58) |
| Median age (IQR) | 47 (35, 68.5) |
| Female | 19 (90.5) |
| Mean body mass index (SD) | 26.47 (8.37) |
| Race | |
| White | 11 (52.4) |
| Hispanic | 9 (42.9) |
| Pacific Islander | 1 (4.8) |
| Etiology | |
| Diabetes | 14 (66.7) |
| Idiopathic | 7 (33.3) |
| Mean current domperidone dose (SD) | 67.62 (24.27) |
| Mean highest domperidone dose (SD) | 80 (20.98) |
| Mean duration of domperidone treatment (SD) | 52.33 (22.16) |